Nicox S.A. (ALCOX.PA)
EUR 0.3
(7.19%)
EUR 0.3
(7.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 257 Thousand | 212 Thousand | 8.58 Million | 14.42 Million | - |
| Cost of Revenue | 11.76 Million | -23.34 Million | 1.35 Million | 1.51 Million | - |
| Gross Profit | -11.5 Million | 23.55 Million | 7.23 Million | 12.9 Million | - |
| Operating Expenses | -11.5 Million | 16.51 Million | 25.39 Million | 19.92 Million | -18.33 Million |
| Selling, General and Administrative Expenses | - | 6.76 Million | 6.33 Million | 6.02 Million | 6.59 Million |
| Research and Development Expenses | - | 17.99 Million | 17.91 Million | 12.72 Million | 17.74 Million |
| Other Expenses | -11.5 Million | -2.24 Million | 68 Thousand | 112 Thousand | -42.67 Million |
| Cost and Expenses | 17.76 Million | -6.83 Million | 26.74 Million | 21.43 Million | -18.33 Million |
| Operating Income | -17.5 Million | -34.06 Million | -46.01 Million | -6.76 Million | -18.33 Million |
| Interest Expense | 1.63 Million | 1.63 Million | 2023.00 | 2.2 Million | - |
| Income Tax Expense | -478 Thousand | -504 Thousand | -3.64 Million | 28 Thousand | - |
| Earnings before Tax | -21.42 Million | -31.78 Million | -47.4 Million | -18.07 Million | - |
| Net Income | -20.88 Million | -31.28 Million | -43.76 Million | -18.09 Million | - |
| Earnings Per Share Basic | -0.42 | -0.62 | -1.17 | -0.54 | - |
| Earnings Per Share Diluted | -0.42 | -0.62 | -1.17 | -0.54 | - |
| Weighted Average Shares Outstanding | 50.17 Million | 50.1 Million | 37.48 Million | 33.71 Million | 33.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.17 Million | 50.1 Million | 37.48 Million | 33.71 Million | 33.71 Million |
| Gross Margin | -44.76 | 111.12 | 0.84 | 0.89 | - |
| EBIT Margin | -63.18 | -85.38 | 1.37 | -0.98 | - |
| Profit Margin | -81.25 | -147.57 | -5.10 | -1.25 | - |
| EBITDA | -16.23 Million | -18.1 Million | -15.96 Million | -14.12 Million | -18.33 Million |
| Earnings Before Tax Margin | -68.11 | -160.67 | -5.36 | -0.47 | - |
| Breakdown | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2021 FY |
|---|---|---|---|---|---|---|
| Revenue | 257 Thousand | 866.50 | 866.50 | 212 Thousand | 920.50 | 8.58 Million |
| Cost of Revenue | 11.76 Million | 3345.00 | 3345.00 | -23.34 Million | 5107.00 | 1.35 Million |
| Gross Profit | -11.5 Million | -2478.50 | -2478.50 | 23.55 Million | -4186.50 | 7.23 Million |
| Operating Expenses | 6 Million | 1643.00 | 1643.00 | 16.51 Million | 2162.50 | 25.39 Million |
| Selling, General and Administrative Expenses | - | 1755.50 | 1755.50 | - | 1877.50 | - |
| Research and Development Expenses | - | 3345.00 | 3345.00 | - | 5107.00 | - |
| Other Expenses | -3.04 Million | -3457.50 | -3457.50 | -2.24 Million | -4822.00 | 68 Thousand |
| Cost and Expenses | 17.76 Million | 4988.00 | 4988.00 | -6.83 Million | 7269.50 | 26.74 Million |
| Operating Income | -19.78 Million | -4121.50 | -4121.50 | -34.06 Million | -6349.00 | -46.01 Million |
| Interest Expense | 1.63 Million | - | - | 1.63 Million | - | 2.02 Million |
| Income Tax Expense | -478 Thousand | 10.00 | 10.00 | -504 Thousand | 424.50 | -3.64 Million |
| Earnings before Tax | -21.42 Million | -3293.00 | -3293.00 | -31.78 Million | -5801.00 | -47.4 Million |
| Net Income | -20.88 Million | -3303.00 | -3303.00 | -31.28 Million | -5376.50 | -43.76 Million |
| Earnings Per Share Basic | - | -0.00 | -0.07 | - | -0.12 | - |
| Earnings Per Share Diluted | - | -0.00 | -0.07 | - | -0.12 | - |
| Weighted Average Shares Outstanding | 50.17 Million | 50.14 Million | 50.14 Million | 50.1 Million | 44.74 Million | 37.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.17 Million | 50.14 Million | 50.14 Million | 50.1 Million | 44.74 Million | 37.48 Million |
| Gross Margin | -44.76 | -2.86 | -2.86 | 111.12 | -4.55 | 0.84 |
| EBIT Margin | - | -4.81 | -4.81 | - | -5.80 | - |
| Profit Margin | -81.25 | -3.81 | -3.81 | -147.57 | -5.84 | -5.10 |
| EBITDA | - | -4172.00 | -4172.00 | - | -5339.50 | - |
| Earnings Before Tax Margin | -77.00 | -4.76 | -4.76 | -160.67 | -6.90 | -5.36 |
SBN
MBSS
003003
EHTH
INDR
ASTH